
STROMUSC Superior Quality DHB(1-Testosterone Cypionate)10mg For Bodybuilding CAS:65-06-5
1-Testosterone (dihydroboldenone) is not a prodrug to testosterone; it is a distinct entity. Chemically, it is boldenone with a double bond between carbons 1 and 2, but unlike boldenone, it does not aromatize. The cypionate ester attached to the 17-beta hydroxyl group in this "DHB" version serves to extend the release profile. However, here is where the nuance lies: 1-Testosterone is a 5 -reduced androgen.
1-Testosterone (dihydroboldenone) is not a prodrug to testosterone; it is a distinct entity. Chemically, it is boldenone with a double bond between carbons 1 and 2, but unlike boldenone, it does not aromatize. The cypionate ester attached to the 17-beta hydroxyl group in this "DHB" version serves to extend the release profile. However, here is where the nuance lies: 1-Testosterone is a 5 -reduced androgen. This means it is already reduced at the 5-alpha position, rendering it incapable of converting to dihydrotestosterone (DHT) or estrogens. In injectable form, the cypionate ester provides a slow release; in tablet form, we are likely dealing with a micronized, lipophilic formulation designed to bypass first-pass metabolism to a degree, though oral bioavailability remains the Achilles' heel of this molecule.
Unlike methasterone or methylated orals, DHB does not carry a 17-alpha-alkylation. If these tablets are indeed non-alkylated, their hepatotoxicity is significantly lower than traditional orals, but their bioavailability hinges on advanced delivery systems (cyclodextrins or lipid matrices) to survive hepatic breakdown. This makes "Superior Quality" a critical qualifier-most attempts at oral DHB fail due to poor absorption, leaving users with suppressed natural testosterone and minimal anabolic return.


The features of this compound distinguish it from conventional anabolics like testosterone cypionate or nandrolone. First, its is exceptionally high-higher than testosterone itself, yet its androgenic effects in peripheral tissues (scalp, prostate) are muted because it does not reduce to a more potent androgen; it the potent androgen. This paradox results in a compound that builds tissue with a level of density rarely seen outside of trenbolone or masteron, but without the same neurological aggression or prolactin issues.
means estrogen management is nonexistent with this compound alone. This is a double-edged sword. While it eliminates water retention, gynecomastia, and high blood pressure from estrogen, it also removes the neuroprotective and anabolic synergy that estrogen provides in a cycle. Users often describe the physique changes from DHB as "hard" and "grainy"-subcutaneous water is shed, and muscle fullness takes on a dry, compact appearance.
in tablet form is a biochemical gamble. Typically, esters are used in injections to control dissolution rate. In an oral tablet, the ester likely serves to protect the molecule during digestion or to facilitate absorption through the lymphatic system rather than the portal vein. This is a sophisticated formulation; if done correctly, it yields a half-life that extends beyond 24 hours, allowing for once-daily dosing. If done poorly, it results in gastrointestinal distress and negligible serum levels.
In the context of bodybuilding, DHB occupies a niche for the advanced user who has exhausted the utility of traditional compounds. It is not a beginner's drug. Its applications center on .
For a competitor in a cutting phase, DHB acts as a protective agent against catabolism while enhancing muscular density. Because it does not cause estrogenic water retention, the weight gained on DHB is "real" tissue-muscle fiber hypertrophy without the illusion of size from subcutaneous fluid. For the off-season athlete, it serves as a tool to add quality mass while keeping blood pressure and insulin sensitivity in check, provided diet is structured.
The 10mg tablet format forces a rethinking of dosing frequency. Unlike injectable DHB, which is often dosed at 300-600mg per week, the oral version requires a total weekly load that accounts for bioavailability loss. Experienced users often report that 40mg to 60mg per day (split into two doses due to the half-life) yields results comparable to 300-400mg of injectable DHB, assuming the tablet formulation is superior. This makes it a viable option for those who are needle-averse but still seeking the unique anabolic profile of 1-testosterone.
The benefits of this specific compound, in this specific format, extend into realms that are often overlooked in standard anabolic discourse.
1.Collagen Synthesis and Joint Integrity: Unlike Winstrol or Anavar, which can dry joints to the point of pain, DHB has been observed in anecdotal reports to support collagen synthesis. Because it does not interfere with estrogen to the point of total elimination, and because its androgenic activity supports fibroblast proliferation, users often report that strength increases are accompanied by joint resilience rather than degradation. This is critical for bodybuilders who push heavy compound movements during mass phases.
2.Metabolic Flexibility: DHB appears to have a positive effect on nutrient partitioning. Its structure allows it to bind to the androgen receptor with a high affinity, promoting lipolysis while simultaneously shunting amino acids into skeletal muscle. Users often note that they can maintain a caloric surplus with minimal fat accumulation, or a caloric deficit without muscle loss-a balance that is notoriously difficult to strike with harsher compounds like trenbolone.
3.Neurosteroid Activity: Because 1-Testosterone is a 5 -reduced androgen, it has the potential to interact with GABA-A receptors in a manner distinct from other anabolics. The result is often a sense of "calm focus" rather than the agitation associated with trenbolone or high-dose testosterone. This makes it psychologically tolerable for longer cycles, though individual responses vary.
4.Reduced Hematocrit Impact: Compared to testosterone, DHB tends to have a milder effect on erythrocytosis. For athletes concerned about blood thickness and cardiovascular strain, this is a significant advantage. The absence of estrogen also means less renin-angiotensin-aldosterone system activation, leading to lower fluid retention and, consequently, more stable blood pressure readings during the cycle.
Designing a cycle around 10mg tablets requires a departure from conventional protocols. Given the half-life of the cypionate ester-approximately 4 to 5 days in injectable form, but potentially compressed in oral delivery-steady-state serum levels are achieved through daily administration.
●Weeks 1-8: 50mg per day (five 10mg tablets), split into two doses (30mg upon waking, 20mg 8-10 hours later) to maintain stable plasma concentrations.
: DHB suppresses endogenous testosterone. A concurrent low-dose testosterone enanthate or cypionate (100-150mg per week) is necessary to maintain physiological estrogen levels and support cognitive function, libido, and cardiovascular health. Running DHB without a testosterone base is ill-advised; the resulting low-estrogen state can lead to lethargy, joint pain, and impaired lipid profiles.
: DHB is slow-acting due to its high binding affinity and slow receptor dissociation. Eight to ten weeks is the minimum to see significant morphological changes. Extending to 12 weeks is possible if biomarkers (lipids, liver enzymes, kidney function) remain within acceptable ranges.
For advanced users stacking with non-aromatizing compounds like masteron or primobolan, the DHB dose can be reduced to 30-40mg per day, leveraging synergy rather than high dosage.
Half-Life and Pharmacokinetics
The pharmacokinetics of oral 1-Testosterone Cypionate are speculative but grounded in principle. The cypionate ester is hydrolyzed in the blood by esterases, releasing free 1-testosterone. In oral form, the absorption is likely split: a portion is absorbed through the intestinal lymphatic system, bypassing the liver initially, while the remainder undergoes first-pass metabolism.
The effective half-life likely ranges between 24 and 36 hours due to the ester. This is shorter than injectable cypionate (which can be 5-7 days) because the oral route introduces variables like gut transit time and enzymatic degradation in the gastrointestinal tract. Steady-state is typically achieved within 5 to 7 days of daily dosing. Users report that the compound's effects-increased pumps, enhanced recovery, and a gradual hardening of muscle tissue-become evident by the end of the second week.
Post-Cycle Therapy (PTC – Properly PCT)
Post-Cycle Therapy for DHB is distinct due to the compound's profound suppression of the HPTA axis. 1-Testosterone is a potent androgen; exogenous administration will shut down natural testosterone production swiftly. Furthermore, because DHB does not aromatize, the negative feedback loop on the hypothalamus is driven purely by androgenic signaling, which can be aggressive.
A proper PCT protocol must account for the ester's clearance. Users should wait 14 to 18 days after the last tablet to begin PCT, allowing the cypionate ester to clear sufficiently so that SERMs (Selective Estrogen Receptor Modulators) are not competing with residual exogenous androgen.
●Week 1-2 (Bridge): If testosterone was used alongside DHB, continue a low-dose HCG (Human Chorionic Gonadotropin) at 500 IU every other day for the first two weeks post-cycle to stimulate Leydig cell desensitization reversal. Discontinue HCG before starting SERMs.
●Week 3-6:
○Clomiphene (Clomid): 50mg daily for the first two weeks, then 25mg daily for the final two weeks.
○Tamoxifen (Nolvadex): 20mg daily for four weeks.
: Add a natural testosterone booster containing ashwagandha or fenugreek to aid in libido restoration, though the primary work is done by SERMs.
Crucially, because DHB does not cause estrogen spikes, there is no risk of "rebound gynecomastia" during PCT. The focus is purely on restoring the HPTA axis and managing the psychological dip that often accompanies the cessation of a potent androgen.
●Lipid Profiles: DHB, like most anabolic agents, suppresses HDL cholesterol. Daily dosing of an oral androgen exacerbates this. Supplement with omega-3 fatty acids, citrus bergamot, and maintain a diet low in saturated fats during the cycle.
●Androgenic Side Effects: While milder than DHT derivatives, DHB can still accelerate male pattern baldness in genetically predisposed individuals and increase sebum production. A topical anti-androgen like RU58841 or ketoconazole shampoo can mitigate scalp issues.
●Cardiovascular Strain: Monitor blood pressure weekly. The dry nature of the compound does not preclude hypertension; increased cardiac output and vascular remodeling can elevate BP.
|
1-Testo; 1-T; δ1-Dihydrotestosterone; δ1-DHT; |
|
|
65-06-5 |
|
|
288.431 |
|
|
C19H28O2 |
|
|
Above 98% |
|
|
10mg*100 |
Email: Jasonraws106@gmail.com
WhatsApp: +86-15572565525
Telegram: +86-15871669785

Superior Quality DHB (1-Testosterone Cypionate) 10mg tablets represent a convergence of niche pharmacology and advanced formulation. They offer a pathway to dense, dry muscle tissue acquisition with a side effect profile that, when managed, is distinct from both traditional orals and harsher 19-nor compounds. However, they demand respect for their potency, a rigorous approach to cycle support, and a disciplined PCT.
Populære tags: stromusc superior quality dhb(1-testosterone cypionate)10mg for bodybuilding cas:65-06-5, China stromusc superior quality dhb(1-testosterone cypionate)10mg for bodybuilding cas:65-06-5 manufacturers, suppliers, factory
